The Filing Desk

Allarity Therapeutics vs Clene

Allarity Therapeutics ALLR · Clene CLNN · Pharmaceuticals

Allarity Therapeutics reported revenue of $0 million in fiscal 2025, 1.5 times Clene's $0 million in fiscal 2025. Allarity Therapeutics had an operating margin of -3939.1%, against -11541.5% at Clene. Free cash flow was −$15 million at Allarity Therapeutics and −$19 million at Clene.

Side by side

Allarity TherapeuticsClene
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$0M$0M
Revenue growth—−41.5%
Revenue growth a year, last 5 years—0.0%
Gross margin—78.5%
Operating margin−3,939.1%−11,541.5%
Net margin−3,509.7%−13,086.5%
Free cash flow−$15M−$19M
Free cash flow margin−4,633.8%−9,292.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$3M$0M
Change in diluted share count794.8%41.8%
Last close$0.86$3.50
P/E at the last close——
Insider trades, last 12 months—bought $250,904, sold $5.8 million
Piotroski F-score—2 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Allarity TherapeuticsClene
Operating margin
Percent of revenue
Allarity TherapeuticsClene
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Allarity TherapeuticsClene

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Allarity Therapeutics and Clene pages.